YEU-11903-48019
1 vaccination
7 coded responses
11 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 457 / OH
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Moderna
-
2021-01-16
Survey response — day 0, dose 1MedDRA: Nasal congestion — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-18
- 2021-01-19
-
2021-01-21
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: Fair · Fatigue or tirednessFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: Fair · Fatigue or tirednessFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Survey response — day 7, dose 1MedDRA: Respiratory tract congestion — Feeling: Fair · Fatigue or tirednessFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — day 14, dose 1MedDRA: Ageusia, Anosmia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Loss of taste and smell.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-06
Survey response — day 21, dose 1MedDRA: Respiratory tract congestion — Feeling: FairFree text: Chest congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-13
- 2021-02-14
-
2021-02-20
Survey response — day 35, dose 1MedDRA: Wheezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: WheezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Report sent to call center — day 35, dose 1Be unable to do your normal daily activities1 call case(s)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | Unsuccessful | |
| 2021-01-30 | Unsuccessful | |
| 2021-02-20 | priority 2/3 |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Nasal congestion
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Congestion
Systemic reaction (other): Congestion
Release 2 — day 7, dose 1
Systemic reaction (other): Congestion
Release 3 — day 14, dose 1
Symptoms: Loss of taste and smell.
Release 3 — day 21, dose 1
Symptoms: Chest congestion
Release 4 — day 35, dose 1
Symptoms: Wheezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Wheezing | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release